Patents by Inventor Takaaki Koshiba

Takaaki Koshiba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8512940
    Abstract: The present invention provides a liver preservation solution containing trehalose and dibutyryl-cAMP. The content of nitroglycerin in the preservation solution is preferably lower than 0.44 mM. In the liver preservation solution of the present invention, since the toxicity due to nitroglycerin, which is observed during liver preservation, has been improved, liver transplantation can be performed with a high engrafted rate.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: August 20, 2013
    Assignee: Otsuka Pharmaceutical Factory, Inc.
    Inventors: Takaaki Koshiba, Xiangdong Zhao, Hiromi Wada, Koichi Tanaka, Masami Nakamura
  • Publication number: 20110311959
    Abstract: The present invention provides a liver preservation solution containing trehalose and dibutyryl-cAMP. The content of nitroglycerin in the preservation solution is preferably lower than 0.44 mM. In the liver preservation solution of the present invention, since the toxicity due to nitroglycerin, which is observed during liver preservation, has been improved, liver transplantation can be performed with a high engrafted rate.
    Type: Application
    Filed: August 31, 2011
    Publication date: December 22, 2011
    Inventors: Takaaki Koshiba, Xiangdong Zhao, Hiromi Wada, Takayuki Nakamura, Masami Nakamura, Koichi Tanaka
  • Publication number: 20090297539
    Abstract: The present invention provides a method of producing a regulatory T cell, which includes culturing a peripheral CD25+CD4+ T cell of a naive phenotype to give the regulatory T cell. The CD25+CD4+ T cell can be cultured under stimulation with an antigen. According to the method, a mammalian regulatory T cell can be produced in vitro and an antigen-specific regulatory T cell can also be produced. The regulatory T cell produced by the method is useful as an immunomodulator for the prophylaxis or treatment of rejection reaction in organ transplantation, allergic disease, autoimmune disease, graft-versus-host disease (GVHD), infertility and the like.
    Type: Application
    Filed: March 31, 2006
    Publication date: December 3, 2009
    Applicant: KYOTO UNIVERSITY
    Inventors: Takaaki Koshiba, Atsushi Ito, Koichi Tanaka, Shimon Sakaguchi
  • Publication number: 20090246212
    Abstract: The present invention provides a screening method for a compound capable of inducing regulatory T cells, comprising the following steps: (1) a step for culturing CD4+ T cells having a naïve phenotype in the presence of a test compound, and isolating T cells from the culture product; (2) a step for evaluating the immunosuppressive function of the T cells isolated in the step (1); (3) a step for obtaining the foregoing test compound as a compound capable of inducing regulatory T cells if the results of the evaluation in the step (2) show that the T cells isolated in the step (1) have immunosuppressive function. The present invention also provides a method of producing regulatory T cells, comprising culturing CD4+ T cells having a naïve phenotype in the presence of a rapamycin compound to obtain regulatory T cells.
    Type: Application
    Filed: September 29, 2006
    Publication date: October 1, 2009
    Applicant: KYOTO UNIVERSITY
    Inventors: Takaaki Koshiba, Atsushi Ito, Shimon Sakaguchi, Koichi Tanaka, Yanling Wu, Mayuko Narumoto
  • Publication number: 20090239206
    Abstract: The present invention provides a liver preservation solution containing trehalose and dibutyryl-cAMP. The content of nitroglycerin in the preservation solution is preferably lower than 0.44 mM. In the liver preservation solution of the present invention, since the toxicity due to nitroglycerin, which is observed during liver preservation, has been improved, liver transplantation can be performed with a high engrafted rate.
    Type: Application
    Filed: October 12, 2006
    Publication date: September 24, 2009
    Inventors: Takaaki Koshiba, Xiangdong Zhao, Hiromi Wada, Takayuki Nakamura, Masami Nakamura, Koichi Tanaka